Abstract:Abstract Progress in oligonucleotide chemistry has produced a shift in the nature of siRNA used, from formulated, minimally modified siRNAs, to unformulated, heavily modified siRNA conjugates. The introduction of extensive chemical modifications is essential for conjugate-mediated delivery. Modifications have a significant impact on siRNA efficacy through interference with recognition and processing by RNAi enzymatic machinery, severely restricting the sequence space available for siRNA design. Many algorithms available publicly can successfully predict the activity of non-modified siRNAs, but the efficiency of the algorithms for designing heavily modified siRNAs has never been systematically evaluated experimentally. Here we screened 356 cholesterol-conjugated siRNAs with extensive modifications and developed a linear regression-based algorithm that effectively predicts siRNA activity using two independent datasets. We further demonstrate that predictive determinants for modified and non-modified siRNAs differ substantially. The algorithm developed from the non-modified siRNAs dataset has no predictive power for modified siRNAs and vice versa. In the context of heavily modified siRNAs, the introduction of chemical asymmetry fully eliminates the requirement for thermodynamic bias, the major determinant for non-modified siRNA efficacy. Finally, we demonstrate that in addition to the sequence of the target site, the accessibility of the neighboring 3′ region significantly contributes to siRNA efficacy.

Chemically Modified Sirnas and Their Conjugates

RNA Interference with Chemically Modified Sirna.

Recent Progress on Sirna Conjugates

Chemical Modification and Delivery System of Small Interfering RNA Drugs

Chemically Modified Platforms for Better RNA Therapeutics

Optimization in Chemical Modification of Single-Stranded Sirna Encapsulated by Neutral Cytidinyl/Cationic Lipids

Synthesis And Properties Of Novel L-Isonucleoside Modified Oligonucleotides And Sirnas

Current Aspects of Sirna Bioconjugate for in Vitro and in Vivo Delivery

Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability

A Large-Scale Chemical Modification Screen Identifies Design Rules to Generate Sirnas with High Activity, High Stability and Low Toxicity.

Research Progress on Sirna Delivery with Nonviral Carriers

Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation

Comprehensive Analysis of Sequence-Specific Stability of Sirna

Nanoparticle‐Mediated Sirna Delivery and Multifunctional Modification Strategies for Effective Cancer Therapy

Sirna Mediated Inhibition of Pancreatic Tumor Growth in Vitro and in Vivo

Lipid-Based Nanoparticles in the Systemic Delivery of Sirna

Functional features defining the efficacy of cholesterol-conjugated, self-deliverable, chemically modified siRNAs

Site-Specific Modification Using the 2′-Methoxyethyl Group Improves the Specificity and Activity of Sirnas

Improving the Potency Prediction for Chemically Modified siRNAs through Insights from Molecular Modeling Focused on Individual Sequence Positions

Synthetic SiRNA Delivery: Progress and Prospects

Chemical modulation of siRNA lipophilicity for efficient delivery